26.12.2012 Views

IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC ...

IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC ...

IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Table 10 (contd)<br />

Reference<br />

(country)<br />

Kogevinas<br />

et al.<br />

1994a,b)<br />

(six European<br />

countries)<br />

Wong et al.<br />

(1994)<br />

(USA)<br />

Anttila et al.<br />

(1998)<br />

(Finland)<br />

Type of plant; study period;<br />

number of subjects; minimal<br />

period employed; follow-up<br />

Production of glass fibrereinforced<br />

plastics (660<br />

facilities); 1945–91; varies<br />

between cohorts; 40 688<br />

workers;<br />

97%<br />

Reinforced plastics<br />

manufacturing plants (n = 30);<br />

1948–89; 15 826 subjects;<br />

6 months; 96.5%<br />

Database of workers<br />

biologically monitored for<br />

urinary mandelic acid;<br />

1973–92; 2580 subjects;<br />

no minimal employment;<br />

98.5%<br />

No of<br />

deaths/<br />

cancer<br />

deaths<br />

Results<br />

2714/686 39<br />

21<br />

37<br />

235<br />

18<br />

60<br />

28<br />

1628/425 36<br />

19<br />

162<br />

14<br />

8<br />

31<br />

11<br />

NR/48 1<br />

6<br />

3<br />

5<br />

5<br />

6<br />

2<br />

No. SMR/<br />

SIR<br />

0.77<br />

0.62<br />

1.0<br />

0.99<br />

0.62<br />

0.93<br />

1.0<br />

1.2<br />

1.1<br />

1.4<br />

0.62<br />

0.59<br />

0.82<br />

0.74<br />

0.36<br />

3.1<br />

1.7<br />

0.59<br />

0.62<br />

1.6<br />

0.39<br />

95% CI Site<br />

0.55–1.1<br />

0.38–0.95<br />

0.71–1.4<br />

0.87–1.1<br />

0.37–0.98<br />

0.71–1.2<br />

0.69–1.5<br />

0.83–1.6<br />

0.68–1.8<br />

1.20–1.6<br />

0.34–1.1<br />

0.25–1.2<br />

0.56–1.2<br />

0.37–1.3<br />

0.01–2.0<br />

1.14–6.8<br />

0.34–4.9<br />

0.19–1.4<br />

0.20–1.5<br />

0.59–3.5<br />

0.05–1.4<br />

Colon<br />

Rectum<br />

Pancreas<br />

Lung<br />

Brain<br />

L&H<br />

Leukaemia<br />

Large intestine<br />

Pancreas<br />

Bronchus, trachea, lung<br />

Breast<br />

Central nervous system<br />

L&H<br />

Leukaemia and<br />

aleukaemia<br />

Colon<br />

Rectum<br />

Pancreas<br />

Lung, trachea<br />

Breast<br />

Nervous system<br />

L&H<br />

Comments (previous evaluation)<br />

Risk of L&H increased with latency (p for<br />

trend = 0.012) and with average exposure (p for<br />

trend = 0.019); risk did not increase with<br />

duration of exposure or cumulative exposure.<br />

Non-significant excess risk observed for<br />

pancreas for high cumulative exposure to<br />

styrene (p for trend = 0.068) (<strong>IARC</strong>, 1994a).<br />

Results presented in this table are for the full<br />

cohort which included a non-exposed group.<br />

Higher risk of L&H among workers with<br />

cumulative exposure > 100 ppm–years at<br />

> 20 years since first exposure (SMR, 1.3;<br />

5 deaths); SMR of lung cancer among workers<br />

with cumulative exposure > 100 ppm–years,<br />

1.0 (34 deaths) (<strong>IARC</strong>, 1994a)<br />

Both of the L&H cases were Hodgkin<br />

lymphomas.<br />

466<br />

<strong>IARC</strong> <strong>M<strong>ON</strong>OGRAPHS</strong> VOLUME 82

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!